glp 1 drugs mechanism Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1R Signaling and Functional Molecules

M., Ricciardi, B., Egitto, M., Torre, F., Valentini, G., D'Iddio, S., Bagiella, E., Mallamace, A., and

GLP-1 medications have been life changing for so many people with obesity, says Jody Dushay, MD, an assistant professor of medicine at Harvard Medical School and an endocrinologist at the Beth Israel Deaconess Medical Center in Boston

Alrifai, M

ZW: Investigation, Writing review and editing, Data curation, Visualization

4 Sodium/glucose co-transporter 2 inhibitors Sodium/glucose co-transporter 2 (SGLT2) inhibitors or gliflozins represent a new class of approved oral anti-hyperglycemic drugs widely used in clinical practice for the treatment of type 2 diabetes, alone or in association with metformin (Kalra, 2014

Jorgensen I, Rayamajhi M, Miao EA